Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

por Zhuang, Chun-Lan, Lin, Zhi-Jie, Bi, Zhao-Feng, Qiu, Ling-Xian, Hu, Fang-Fang, Liu, Xiao-Hui, Lin, Bi-Zhen, Su, Ying-Ying, Pan, Hui-Rong, Zhang, Tian-Ying, Huang, Shou-Jie, Hu, Yue-Mei, Qiao, You-Lin, Zhu, Feng-Cai, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Publicado 2021

Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 t...

por Mo, Zhao-Jun, Bi, Zhao-Feng, Sheng, Wei, Chen, Qi, Huang, Teng, Li, Ming-Qiang, Cui, Xue-Lian, Wangjiang, Ya-Hui, Lin, Bi-Zhen, Zheng, Feng-Zhu, Sun, Guang, Li, Ya-Fei, Zheng, Ya, Zhuang, Si-Jie, Su, Ying-Ying, Pan, Hui-Rong, Huang, Shou-Jie, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Publicado 2022

Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women

por Hu, Yue-Mei, Guo, Meng, Li, Chang-Gui, Chu, Kai, He, Wen-Gang, Zhang, Jing, Gu, Jian-Xiang, Li, Juan, Zhao, Hui, Wu, Xiang-Hong, Lin, BiZhen, Lin, Zhi-Jie, Yao, Xing-Mei, Li, Ya-Fei, Wei, FeiXue, Huang, Yue, Su, Ying-Ying, Zhu, Feng-Cai, Huang, Shou-Jie, Pan, Hui-Rong, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Publicado 2019